SEARCH

SEARCH BY CITATION

References

  • Beaulieu J. M. (2007) Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs. Int. J. Neuropsychopharmacol. 10, 36.
  • Beaulieu J. M., Sotnikova T. D., Yao W. D., Kockeritz L., Woodgett J. R., Gainetdinov R. R. and Caron M. G. (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. USA 101, 50995104.
  • Beaulieu J. M., Sotnikova T. D., Marion S., Lefkowitz R. J., Gainetdinov R. R. and Caron M. G. (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122, 261273.
  • Beaulieu J. M., Sotnikova T. D., Gainetdinov R. R. and Caron M. G. (2006) Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J. Biol. Chem. 281, 3207232080.
  • Beaulieu J. M., Gainetdinov R. R. and Caron M. G. (2007) The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol. Sci. 28, 166172.
  • Beaulieu J. M., Zhang X., Rodriguiz R. M., Sotnikova T. D., Cools M. J., Wetsel W. C., Gainetdinov R. R. and Caron M. G. (2008a) Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc. Natl. Acad. Sci. USA 105, 13331338.
  • Beaulieu J. M., Marion S., Rodriguiz R. M., Medvedev I. O., Sotnikova T. D., Ghisi V., Wetsel W. C., Lefkowitz R. J., Gainetdinov R. R. and Caron M. G. (2008b) A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132, 125136.
  • Bilbao A., Parkitna J. R., Engblom D. et al. (2008) Loss of the Ca2+/calmodulin-dependent protein kinase type IV in dopaminoceptive neurons enhances behavioral effects of cocaine. Proc. Natl. Acad. Sci. USA 105, 1754917554.
  • Boye S. M., Grant R. J. and Clarke P. B. (2001) Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats. Neuropharmacology 40, 792805.
  • Bradberry C. W. (2007) Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: areas of agreement, disagreement, and implications for addiction. Psychopharmacology (Berl) 191, 705717.
  • Cadoni C., Solinas M. and Di Chiara G. (2000) Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur. J. Pharmacol. 388, 6976.
  • Carlezon W. A. Jr and Nestler E. J. (2002) Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci. 25, 610615.
  • Chausmer A. L. and Katz J. L. (2001) The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice. Psychopharmacology (Berl) 155, 6977.
  • Cross D. A., Culbert A. A., Chalmers K. A., Facci L., Skaper S. D. and Reith A. D. (2001) Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J. Neurochem. 77, 94102.
  • De Sarno P., Li X. and Jope R. S. (2002) Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43, 11581164.
  • Di Chiara G., Bassareo V., Fenu S., De Luca M. A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V. and Lecca D. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47(Suppl. 1), 227241.
  • Embi N., Rylatt D. B. and Cohen P. (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107, 519527.
  • Gong W., Neill D. B., Lynn M. and Justice J. B. Jr (1999) Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience 93, 13491358.
  • Gould T. D. and Manji H. K. (2005) Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30, 12231237.
  • Green T. A., Brown R. W., Phillips S. B., Dwoskin L. P. and Bardo M. T. (2002) Locomotor stimulant effects of nornicotine: role of dopamine. Pharmacol. Biochem. Behav. 74, 8794.
  • Heidari P., Sahebgharani M., Riazi G. and Zarrindast M. R. (2006) Influence of morphine and dopamine receptor sensitization on locomotor activity in mice. Pharmacology 78, 185192.
  • Hernandez F., Borrell J., Guaza C., Avila J. and Lucas J. J. (2002) Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. J. Neurochem. 83, 15291533.
  • Hooper C., Markevich V., Plattner F. et al. (2007) Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. Eur. J. Neurosci. 25, 8186.
  • Ikemoto S. and Wise R. A. (2004) Mapping of chemical trigger zones for reward. Neuropharmacology 47(Suppl. 1), 190201.
  • Ito R., Robbins T. W. and Everitt B. J. (2004) Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat. Neurosci. 7, 389397.
  • Jongen-Relo A. L., Voorn P. and Groenewegen H. J. (1994) Immunohistochemical characterization of the shell and core territories of the nucleus accumbens in the rat. Eur. J. Neurosci. 6, 12551264.
  • Jope R. S. (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24, 441443.
  • Jope R. S. and Johnson G. V. (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95102.
  • Kalivas P. W. (2004) Recent understanding in the mechanisms of addiction. Curr. Psychiatry. Rep. 6, 347351.
  • Kalivas P. W. and Stewart J. (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 16, 223244.
  • Kimura T., Yamashita S., Nakao S., Park J. M., Murayama M., Mizoroki T., Yoshiike Y., Sahara N. and Takashima A. (2008) GSK-3beta is required for memory reconsolidation in adult brain. PLoS ONE 3, e3540.
  • Koob G. F. and Nestler E. J. (1997) The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9, 482497.
  • Koros E. and Dorner-Ciossek C. (2007) The role of glycogen synthase kinase-3beta in schizophrenia. Drug News Perspect. 20, 437445.
  • Lecca D., Cacciapaglia F., Valentini V., Acquas E. and Di Chiara G. (2007) Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat. Psychopharmacology (Berl) 191, 653667.
  • Li Y. Q., Li F. Q., Wang X. Y., Wu P., Zhao M., Xu C. M., Shaham Y. and Lu L. (2008) Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J. Neurosci. 28, 1324813257.
  • Lovestone S., Killick R., Di Forti M. and Murray R. (2007) Schizophrenia as a GSK-3 dysregulation disorder. Trends Neurosci. 30, 142149.
  • Lu L., Hope B. T., Dempsey J., Liu S. Y., Bossert J. M. and Shaham Y. (2005) Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat. Neurosci. 8, 212219.
  • Malenka R. C. (2003) Synaptic plasticity and AMPA receptor trafficking. Ann. NY Acad. Sci. 1003, 111.
  • Noh M. Y., Koh S. H., Kim Y., Kim H. Y., Cho G. W. and Kim S. H. (2008) Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death. J. Neurochem. 10, 10.
  • Nordquist R. E., Vanderschuren L. J., Jonker A. J., Bergsma M., De Vries T. J., Pennartz C. M. and Voorn P. (2008) Expression of amphetamine sensitization is associated with recruitment of a reactive neuronal population in the nucleus accumbens core. Psychopharmacology (Berl) 198, 113126.
  • Peineau S., Taghibiglou C., Bradley C. et al. (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53, 703717.
  • Pierce R. C. and Kalivas P. W. (1995) Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275, 10191029.
  • Pierce R. C. and Kalivas P. W. (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res. Rev. 25, 192216.
  • Pierce R. C., Meil W. M. and Kalivas P. W. (1997) The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology (Berl) 133, 188195.
  • Pierce R. C., Quick E. A., Reeder D. C., Morgan Z. R. and Kalivas P. W. (1998) Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 286, 11711176.
  • Poo M. M. (2001) Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2, 2432.
  • Prickaerts J., Moechars D., Cryns K., Lenaerts I., Van Craenendonck H., Goris I., Daneels G., Bouwknecht J. A. and Steckler T. (2006) Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J. Neurosci. 26, 90229029.
  • Robinson T. E. (1984) Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berl) 84, 466475.
  • Robinson T. E. and Becker J. B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396, 157198.
  • Robinson T. E. and Berridge K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18, 247291.
  • Robinson T. E. and Berridge K. C. (2003) Addiction, a review. Annu. Rev. Psychol. 54, 2553.
  • Robinson T. E. and Berridge K. C. (2008) Review. The incentive sensitization theory of addiction: some current issues. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 31373146.
  • Robinson T. E. and Kolb B. (1999) Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11, 15981604.
  • Robinson T. E., Gorny G., Mitton E. and Kolb B. (2001) Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39, 257266.
  • Sotnikova T. D., Beaulieu J. M., Barak L. S., Wetsel W. C., Caron M. G. and Gainetdinov R. R. (2005) Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS Biol. 3, e271.
  • Sweatt J. D. (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76, 110.
  • Thomas M. J., Kalivas P. W. and Shaham Y. (2008) Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br. J. Pharmacol. 154, 327342.
  • Vezina P. (2004) Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci. Biobehav. Rev. 27, 827839.
  • White F. J., Hu X. T. and Zhang X. F. (1997) DA D2 receptors in the ventral striatum: multiple effects or receptor subtypes? Nihon Shinkei Seishin Yakurigaku Zasshi 17, 9195.
  • Zhu L. Q., Wang S. H., Liu D., Yin Y. Y., Tian Q., Wang X. C., Wang Q., Chen J. G. and Wang J. Z. (2007) Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairements. J. Neurosci. 27, 1221112220.